Marketresearchnews

Tuesday, 2 March 2021

Medical Image Management Market In Depth Study And Analysis Published, 2025

Global Medical Image Management Market is expected to register a CAGR of 7.80% to reach USD 5,971.28 Million till 2025. Medical image management systems are used in hospitals and diagnostic centers for sharing patient data and laboratory results with physicians. These systems are very useful and help in maintaining patient data, which plays an important role in clinical decision making.

The rising prevalence of chronic diseases, increasing spending on the healthcare it sector, and technological advancements in diagnostics sector are expected to enhance the market growth. However, the high costs of software solutions and privacy and security concerns are projected to curb the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8312

Market Dynamics

The market is expected to witness a profitable growth owing to the rising prevalence of chronic diseases. According to the data by the Government of Canada, in 2017, about 2.3 million people aged 12 and older were diagnosed with diabetes. Additionally, according to the press release by Chiron Health published in June 2016, chronic diseases such as heart disease, stroke, cancer, depression, type 2 diabetes, obesity, and arthritis affected an estimated 117 million people in the Americas. The medical image management technology could be used to address the issues related to the data collection and sharing of laboratory results and rising demand for healthcare services related to the diagnosis of cancer, diabetes, and other diseases in the North American region.

Thus, the rising prevalence of chronic diseases is expected to drive the growth of the global medical image management market.

Segmentation

The global medical image management market, by product, has been segmented into picture archiving and communication system, vendor-neutral archive (VNA), application-independent clinical archives, and enterprise viewers/universal viewers.Based on end user, the medical image management market has been categorized as hospitals, diagnostic imaging centers, and others.

Regional Analysis

The global medical image management market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas accounted for the largest market in 2018 and is estimated to dominate the global medical image management market owing to the increasing prevalence of chronic diseases, rising adoption of healthcare IT by healthcare bodies, and an increasing number of medical imaging procedures performed.

Europe acquired the second largest market share in 2018. It is expected to register a CAGR of 8.12% by the end of the forecast period. The European market is expected to register a sturdy growth rate during the forecast period due to major driving factors such as the rising patient population of strokes and cardiovascular disorders, increasing research on ultrasound, and availability of advanced treatment facilities amongst others. For instance, according to the 2017 statistics presented by the European Society of Cardiology, there were more than 6 million new cases of cardiovascular diseases in the European Union and more than 11 million in Europe as a whole.

Asia-Pacific is expected to witness significant growth and is projected to be the fastest-growing region over the forecast period. The high growth rate is due to the rising demand for medical practitioners to produce appropriate vascular, orthopedic, breast, and cardiac images and integration of reports, images, and measurements into a patient’s complete record. India held a share of 17.8% in the Asia-Pacific medical image management market in 2018.

The Middle East & Africa accounted for the least market in 2018 and is forecasted to exhibit steady growth due to the high price of devices, lack of awareness regarding health, and lack of skilled professionals.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-image-management-market-8312

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Orthokeratology Lens Market Expected To Grow At High Cagr During Forecast Period 2020 – 2025

Global Orthokeratology Lens Market is expected to register a CAGR of 7.4% to reach USD 3,857.8 Million till 2025.

Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. It is a non-surgical method used to correct refractive errors by reshaping the curvature of the cornea to improve object visibility. This procedure is a temporary treatment method used for the correction of myopia, hypermetropia, and other eye-related problems.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8218

The growing prevalence of refractive errors across the globe, advancements in the field of ophthalmology over the past couple of decades and low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is expected to enhance the market growth. However, the availability of alternative treatment methods and risk associated with orthokeratology are projected to curb the growth of the market.

Market Dynamics

A rise in the number of individuals with refractive errors such as myopia, hypermetropia, astigmatism, and presbyopia increases the demand for innovative treatment methods. Myopia is reported as the most common disorder affecting a large number of populations worldwide. The World Health Organization 2018 fact sheet estimated that approximately 1.3 billion people were living with some form of vision impairment. It also reported that 188.5 million patients have a mild vision impairment, 217 million people have moderate to severe vision impairment, and 36 million people are blind, globally. Such a vast population suffering from eye problems boosts market growth during the forecast period.

Segmentation

The global orthokeratology lens market, by material, has been segmented into silicone acrylate, fluorosilicone acrylate, and fluorocarbon acrylate. On the basis of application, the global orthokeratology lens market has been segmented into myopia and hyperopia. Based on end user, the market has been segmented into hospitals and ophthalmic clinic.

Regional Analysis

The global orthokeratology lens market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The Americas is expected to hold the largest share of the global orthokeratology lens market. The growth of the Americas can be attributed to its rising geriatric population and increasing ophthalmological disorders, causing an increased need for diagnosis and therapeutics.

Asia-Pacific is expected to account for the second-largest market share during the forecast period. The factors responsible for market growth in this region are the rising patient population of people with eye disorders, availability of advanced treatment facilities, increasing healthcare expenditure, and the introduction of advanced therapies into the market along with the presence of good healthcare infrastructure. According to the Asian Development Bank, the elderly population in Asia is projected to reach nearly 923 million by 2050.

Europe is estimated to be growing at the fastest pace in the global market due to the increasing cases of eye disorders and increasing government initiatives are driving the growth of the market. According to reports published by the United Kingdom Statistics Authority, in 2015, around 15,900 people were registered as visually impaired.

The orthokeratology lens market in the Middle East & Africa is expected to exhibit the least growth in the global orthokeratology lens market due to factors such as limited access to healthcare affordability issues.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/orthokeratology-lens-market-8218

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Nerve Regeneration Market Pipeline Review, 2020- Identify Key Business Opportunities

Global Nerve Regeneration Market is expected to register a CAGR of 11.34% to reach USD 12695.25 million by 2024. Nerve regeneration products are used to restore damaged nerves to their normal function, and this procedure is primarily used to treat peripheral nerve injuries. This market is witnessing high growth due to factors such as rising neurological disorders, increasing geriatric population prone to nerve-related diseases, and technological advancements.

Rising neurological disorders, increasing geriatric population susceptible to neurological diseases, and technological advancements in the field of nerve regeneration are expected to enhance the market growth. However, high cost and stringent regulatory framework are projected to restrain the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1202

Key Players

The prominent players in the global nerve regeneration market are Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Integra LifeSciences, Abbott, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, and Medtronic.

The players operating in the global nerve regeneration market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

In April 2019, Polyganics increased its production capacity with a new facility at the Zernike Campus, Groningen, to enter a new phase of commercial and research and development (R&D) growth.

In June 2018, NeuroPace launched a Next-Generation RNS System, the world’s only brain-computer interface for the treatment of refractory epilepsy.

Market Dynamics

The rising neurological disorders have primarily driven the global nerve regeneration market. For instance, as per the statistics of World Health Organizations(WHO) in 2017, around 50 million people all over the world were affected by epilepsy. Various other factors, such as increasing geriatric population affected by neurological disorders and technological advancements, are also propelling the growth of the market. Moreover, the high cost of products and stringent regulatory framework are expected to hinder the market growth.

Market Segmentation

Global Nerve Regeneration Market has been segmented into Product, Application, and End User. Based on the product, the market has been segregated into neurostimulation & neuromodulation devices and biomaterials. On the basis of neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Neurostimulation and neuromodulation devices held a share of 4,764.96 USD million in 2018. Internal neurostimulation devices have been further bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation. External neurostimulation devices have been further segmented into transcutaneous electrical nerve stimulation, transcranial magnetic stimulation. Biomaterials have also been classified as nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Based on the application, the market has been categorized as neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and others. Neurostimulation and neuromodulation surgeries have been bifurcated into internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting has been further classified as autografts, allografts, and xenografts. Based on end-user, the market has been divided into end-user, hospitals & clinics, ambulatory surgery centers, and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Alpha-1 Antitrypsin Deficiency Treatment Market Trends And Drivers Analysis 2020 To 2023

Global Alpha-1 Antitrypsin Deficiency Treatment Market is expected to cross USD 2,914.7 Million by 2025 at a CAGR of 10.50%.

Growing product pipeline for alpha-1 antitrypsin drugs and rising prevalence of alpha-1 antitrypsin deficiency are set to drive the market growth for alpha-1 antitrypsin deficiency treatment. Approximately 100,000 people in the US are known to suffer from alpha-1 antitrypsin deficiency.

Rising awareness regarding the alpha-1 antitrypsin deficiency is expected to drive the growth of the global alpha-1 antitrypsin deficiency treatment market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8319

The market is dominated by numerous established players. The key players are involved in product launches, strategic collaborations, and awareness programs to strengthen their market positions. For instance, in November 2018, Grifols S. A. launched the AlfaCare therapy program for training and counseling of patients diagnosed with alpha-1 antitrypsin deficiency.

Market Influencer

The prevalence of alpha-1 antitrypsin deficiency (AATD) is increasing, which is directly responsible for the growth of the global alpha-1 antitrypsin deficiency treatment market. Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major competitors are expected to further boost market growth during the forecast period.

Segmentation

By Drugs:

Alpha-1 Proteinase Inhibitor: The segment is expected to hold the largest market share as it is the only treatment for AATD, which protects the patient from more lung damage.
Bronchodilators: These are used for the treatment of respiratory disorders associated with AATD.
Steroids: These are used specifically for the treatment of chronic obstructive pulmonary disease, which affects the patient along with AATD.
Others: Other treatment options include antibiotics for infections and jaundice associated with AATD and oxygen therapy.

By Route of Administration:

Oral: The segment is expected to hold the largest market share.
Intravenous: The segment is expected to grow at the fastest CAGR.
Inhalation: This route of administration is used specifically for the administration of corticosteroids for treating breathing disorders.
Others: Subcutaneous and intramuscular routes of administration.

By Distribution Channel:

Hospital Pharmacy: The rise in the number of hospitals is likely to be responsible for the largest market size.
Retail Pharmacy: These fulfill the requirement of drugs that are needed for treatment at home.
Online Stores: The fastest-growing segment owing to increase in number of online pharmacies.

By Region

Americas: The region holds the largest share of the market. The market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

Europe: The European alpha-1 antitrypsin deficiency treatment market has been classified as Western Europe and Eastern Europe. The Western European market has further been categorized as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

Asia-Pacific: The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Asia-Pacific alpha-1 antitrypsin deficiency treatment market is projected to be the fastest-growing during the forecast period.

Middle East & Africa: The market in the Middle East & Africa has been divided into the Middle East and Africa.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/alpha-1-antitrypsin-deficiency-treatment-market-8319
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Forensic Swab Market 2020–By Identifying The Key Market Segments And Key Players Holding Market Share

The Global Forensic Swab Market is expected to register 5.8% CAGR and is anticipated to reach USD 49.09 Million by 2023. Forensic swabs are extensively used by forensic scientists and crime scene investigators for collecting a wide range of evidence-samples such as blood, saliva, and DNA. These samples are analyzed in the laboratory for desired results. Gathering biological samples for successive DNA analysis is one of the major applications for forensic swabs. Rising criminal activities, increasing adoption of DNA forensics, growing forensic biotechnology sector, and favorable government support are some of the major factors driving the market growth during the forecast period. However, factors such as the high price of DNA free forensic swabs and irregular supply of new products in the market are projected to restrain the market growth. However, the growing rate of chronic and infectious diseases, increased research and development investment (R&D), and technological advancements are expected to boost the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6929

Market Dynamics

The past few years, there has been an increase in criminal activities and reported crimes has increased. According to crime statistics published by the Federal Bureau of Investigation, approximately 17,250 murders were estimated to be reported within the US in 2016. The government support for forensics-related activities is one of the major factors driving the global forensic swab market. The judicial framework of various countries has realized the importance of forensics. Currently, forensics is being utilized as toxicology forensics, DNA forensics, and others for investigating criminal offenses. According to a report on forensic science published by the National Criminal Justice Reference Service, the National Institute of Justice received a funding of USD 125 million through the Department of Justice Appropriations Act in 2017 for boosting DNA and other related forensic programs and activities and sexual assault forensic exams.

Segmentation

The global forensic swab market has been segmented into type, type of swab shaft, and end user.

Based on type, the global market has been segmented into foam, flocked, and cotton.

Based on type of swab shaft, the global market has been segmented into wood-stick shaft, polystyrene shaft.

Based on end user, the global market has been divided into forensic science laboratories and hospitals.

Key Players

The prominent players in the global forensic swab market are Becton, Dickinson and Company Thermo Fisher Scientific Inc., Merck KGaA, Copan Italia S.p.A., MWE, SARSTEDT AG & Co. KG, Luna, Puritan Medical Products, Sirchie, and MEDTECH Forensics.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/forensic-swab-market-6929

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Non-Invasive Monitoring Device Market 2020 Market Challenge, Driver, Trends & Forecast To 2023

The Global Non-Invasive Monitoring Device Market is expected to register a CAGR of 6.80% and is anticipated to reach USD 21,586.2 Million by 2023. Monitoring the patient condition is one of the significant parts of any treatment process for any disease condition. Monitoring devices are playing a vital role in providing the best possible care to the patients. There are three types of monitoring devices; invasive, minimally invasive, and non-invasive monitoring devices. Non-invasive devices are in high demand from the healthcare providers as well as patients due to their advantages over invasive monitoring. Non-invasive monitors are very much different from invasive monitors in terms of their working principle. Non-invasive monitors do not require rupturing of skin and penetration of any device into the body of the patient. Non-invasive monitors have sensors attached which play an essential role in generating readings of the body vitals.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1506

The increasing prevalence of cardiovascular diseases, increasing adoption of non-invasive technology, increasing prevalence of neurovascular diseases, increasing geriatric population, and favorable reimbursement policies are the major drivers propelling market growth. However, the erroneous readings and stringent regulatory norms constrain the growth of the market.

Market Dynamics

According to a report published in 2015 by the Center for Disease Control and Prevention (CDC), every year, more than 630,000 Americans die from heart diseases. Moreover, according to a report published by the CDC, in 2017, nearly 30.3 million people have diabetes only in the US. That means, one person out of every ten people has diabetes. Increasing prevalence of cardiovascular diseases has created a unique demand for advanced non-invasive monitoring devices. Additionally, increasing risks and patients suffering from diabetes & obesity, developing technology, and growing demand for monitoring devices will fuel the growth of the market during the forecast period.

Segmentation

The global non-invasive monitoring device market has been segmented into type, modality, application, and end user. By type, the market has been segmented into cardiac monitoring devices (electrocardiography and cardiac output monitors), brain monitoring devices, blood pressure monitoring devices, anesthesia monitoring devices, and blood glucose monitoring devices. Based on modality, the market has been segregated into table-top devices and wearable devices. By application, the market has been divided into cardiology, neurology, and oncology. On the basis of end-user, the market has been classified as hospital & clinics, diagnostic centers, and research & academic institutes. The hospitals and clinics segment accounted for a market value of USD 5457.4 million in 2016.

Key Players

The prominent players in the global non-invasive monitoring device market are General Electric Company (US), Medtronic PLC (Ireland), KONINKLIJKE PHILIPS NV (Netherlands), Abbott (US), Omron Corporation (Japan), Vaso Corporation (US), Integrity Applications (Israel), CAS Medical Systems, Inc. (US), A&D Medical Inc. (Japan), Tensys Medical Inc (US), OrSense Ltd (Israel), CNSystems Medizintechnik AG (Austria), NIMedical (Israel) and Advanced Brain Monitoring, Inc (US).

Some of the key strategies followed by the players operating in the global non-invasive monitoring device market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Monday, 1 March 2021

Healthcare IoT Security Market Expected To Boost During 2020 To 2025

The Global Healthcare IoT Security Market is expected to register 39.44% CAGR and is anticipated to reach USD 130,629.55 Million by 2025. Individuals today are using various kinds of networked devices to learn more about their health and daily regime. Home monitoring of aging population related to medical emergencies and medical adherence has become possible due to the increasing use of mHealth applications and smart pills.

However, the rewards of IoT also comes with the aspect of concern regarding the security and the privacy of the patient healthcare data. Mobile and wearable devices, pacemakers, insulin pumps, and other medical systems in the IoT create more access points prone to hackers. The security solutions and services play a critical role for the healthcare organizations to perform vulnerability management and secure the protected health information passing from IoT devices to the healthcare organizations.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/946

Market Dynamics

The market for healthcare IoT security is expected to register double-digit growth during the forecast period. The major factors influencing the growth of the market include increased data privacy concerns among consumers, increased government concerns over healthcare IoT security, increased usage of smart devices for health management and increased proliferation of cybercrimes in healthcare.

With the emergence of IoT in healthcare, consumers can now track their health in real time and simultaneously share healthcare information with their caregivers and healthcare organizations. However, the ease and usage of these devices are also raising security concerns among consumers. As the use of IoT increases, data privacy concerns are bound to increase and hence, will act as a key driver for the healthcare IoT security market, globally.

Segmentation

The global healthcare IoT security market has been segmented into components, security type, application.

Based on component, the global market is divided into solution and service.

Based on solution type, the global market has been segmented into analytics, encryption, data loss protection, identity and access management, unified threat management, and others.

Based on service type, the global market has been segmented into consulting services, risk assessment services, design & integration services, managed security services, and others.

Based on security type, the global market is segmented into application security, cloud security, endpoint security, network security, others security.

Based on application, the global market is segmented into pharmaceutical, medical devices, and biotechnology.

Key Players

The prominent players in the global healthcare IoT security market are Inside Secure SA, IBM Corporation, Cisco Systems Inc., Intel Corporation, Oracle Corporation, Sophos Group plc, Symantec Corporation, Trend Micro Inc, Checkpoint Software Technology, Kaspersky Labs, Fortinet Inc, Intelen Inc, Eurotech SpA, Deutsche telekom AG, SecureFLO LLC, Dell Corporation, Atmel Corporation, Security Mentor, Klynveld Peat Marwick Goerdeler, Agile Cyber Security Solutions, LLC.

Some of the key strategies followed by the players operating in the global healthcare IoT security market are innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-iot-security-market-946

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com